Sex-Related Differences in Atrial Remodeling in Patients With Atrial Fibrillation: Relationship to Ablation Outcomes.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 24 12 2021
medline: 1 3 2022
entrez: 23 12 2021
Statut: ppublish

Résumé

Population studies have demonstrated a range of sex differences including a higher prevalence of atrial fibrillation (AF) in men and a higher risk of AF recurrence in women. However, the underlying reasons for this higher recurrence are unknown. This study evaluated whether sex-based electrophysiological substrate differences exist to account for worse AF ablation outcomes in women. High-density electroanatomic mapping of the left atrium was performed in 116 consecutive patients with AF. Regional analysis was performed across 6 left atrium segments. High-density maps were created using a multipolar catheter (Biosense Webster) during distal coronary sinus pacing at 600 and 300 ms. Mean voltage and conduction velocity was determined. Complex fractionated signals and double potentials were manually annotated. Overall, 42 (36%) were female, mean age was 61±8 years and AF was persistent in 52%. Global mean voltage was significantly lower in females compared with males at 600 ms (1.46±0.17 versus 1.84±0.15 mV, Female patients demonstrated more advanced atrial remodeling on high-density electroanatomic mapping and greater post-AF ablation arrhythmia recurrence compared with males. These changes may contribute to sex-based differences in the clinical course of females with AF and in part explain the higher risk of recurrence. Graphic Abstract: A graphic abstract is available for this article.

Sections du résumé

BACKGROUND
Population studies have demonstrated a range of sex differences including a higher prevalence of atrial fibrillation (AF) in men and a higher risk of AF recurrence in women. However, the underlying reasons for this higher recurrence are unknown. This study evaluated whether sex-based electrophysiological substrate differences exist to account for worse AF ablation outcomes in women.
METHODS
High-density electroanatomic mapping of the left atrium was performed in 116 consecutive patients with AF. Regional analysis was performed across 6 left atrium segments. High-density maps were created using a multipolar catheter (Biosense Webster) during distal coronary sinus pacing at 600 and 300 ms. Mean voltage and conduction velocity was determined. Complex fractionated signals and double potentials were manually annotated.
RESULTS
Overall, 42 (36%) were female, mean age was 61±8 years and AF was persistent in 52%. Global mean voltage was significantly lower in females compared with males at 600 ms (1.46±0.17 versus 1.84±0.15 mV,
CONCLUSIONS
Female patients demonstrated more advanced atrial remodeling on high-density electroanatomic mapping and greater post-AF ablation arrhythmia recurrence compared with males. These changes may contribute to sex-based differences in the clinical course of females with AF and in part explain the higher risk of recurrence. Graphic Abstract: A graphic abstract is available for this article.

Identifiants

pubmed: 34937397
doi: 10.1161/CIRCEP.121.009925
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009925

Auteurs

Geoffrey R Wong (GR)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).
Department of Medicine, University of Melbourne, Australia (G.R.W., C.J.N., R.P., A.A.-K., J.M.K.). Baker Institute, Melbourne, Australia (A.V., D.C., S.P., H.S., L.-H.L., P.M.K.).

Chrishan J Nalliah (CJ)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).
Department of Medicine, University of Melbourne, Australia (G.R.W., C.J.N., R.P., A.A.-K., J.M.K.). Baker Institute, Melbourne, Australia (A.V., D.C., S.P., H.S., L.-H.L., P.M.K.).

Geoffrey Lee (G)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).

Aleksandr Voskoboinik (A)

Heart Centre, Alfred Hospital, Melbourne, Australia (A.V., D.C., S.P., L.-H.L., P.M.K.). Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, Australia (P.S.).

David Chieng (D)

Heart Centre, Alfred Hospital, Melbourne, Australia (A.V., D.C., S.P., L.-H.L., P.M.K.). Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, Australia (P.S.).

Sandeep Prabhu (S)

Heart Centre, Alfred Hospital, Melbourne, Australia (A.V., D.C., S.P., L.-H.L., P.M.K.). Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, Australia (P.S.).

Ramanathan Parameswaran (R)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).
Department of Medicine, University of Melbourne, Australia (G.R.W., C.J.N., R.P., A.A.-K., J.M.K.). Baker Institute, Melbourne, Australia (A.V., D.C., S.P., H.S., L.-H.L., P.M.K.).

Ahmed Al-Kaisey (A)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).
Department of Medicine, University of Melbourne, Australia (G.R.W., C.J.N., R.P., A.A.-K., J.M.K.). Baker Institute, Melbourne, Australia (A.V., D.C., S.P., H.S., L.-H.L., P.M.K.).

Alex McLellan (A)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).

Liang-Han Ling (LH)

Heart Centre, Alfred Hospital, Melbourne, Australia (A.V., D.C., S.P., L.-H.L., P.M.K.). Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, Australia (P.S.).

Peter M Kistler (PM)

Heart Centre, Alfred Hospital, Melbourne, Australia (A.V., D.C., S.P., L.-H.L., P.M.K.). Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, Australia (P.S.).

Jonathan M Kalman (JM)

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (G.R.W., C.J.N., G.L., R.P., A.A.-K., A.M., J.M.K.).
Department of Medicine, University of Melbourne, Australia (G.R.W., C.J.N., R.P., A.A.-K., J.M.K.). Baker Institute, Melbourne, Australia (A.V., D.C., S.P., H.S., L.-H.L., P.M.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH